BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260923
DTEND;VALUE=DATE:20260925
DTSTAMP:20260528T105430Z
CREATED:20260528T105430Z
LAST-MODIFIED:20260528T105430Z
UID:43620-1790121600-1790294399@www.pharmajournalist.com
SUMMARY:5th Lipid Nanoparticles Development Summit Europe
DESCRIPTION:The 5th Lipid Nanoparticles Development Summit Europe returns to Berlin\, 23rd – 24th  September 2026\, as the leading meeting for advancing LNP-enabled gene therapy delivery. Bringing together experts from BioNTech\, AstraZeneca\, Johnson & Johnson\, Sanofi and AbbVie\, the summit covers end-to-end LNP development\, from formulation through to analytics\, CMC and scalable manufacturing. Attendees will explore solutions to overcome liver tropism\, enable extrahepatic delivery and engineer next-generation nanoparticle systems across mRNA\, DNA and gene editing therapies. With interactive discussions and real-world case studies\, this event delivers actionable insights to accelerate safe\, targeted and clinically viable delivery platforms. \nTo learn more and register online\, please visit: https://ter.li/mft1fbw0
URL:http://www.pharmajournalist.com/event/5th-lipid-nanoparticles-development-summit-europe/
LOCATION:Dorint Kurfürstendamm Berlin\, Augsburger Strasse 41\, Berlin\, 10789\, Germany
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR